title: Can asymptomatic patients with a supratherapeutic international normalized ratio be safely treated as outpatients?
authors.affiliation: Department of Medical Toxicology, Banner Good Samaritan Medical Center, Phoenix, AZ, USA. michael.levine@bannerhealth.com
authors.forename: Michael
authors.initials: M
authors.lastname: Levine
authors.forename: Anne-Michelle
authors.initials: AM
authors.lastname: Ruha
authors.forename: Joshua N
authors.initials: JN
authors.lastname: Goldstein
mesh_terms: D000553:Ambulatory Care; D000925:Anticoagulants / Q000009:adverse effects*; D058070:Asymptomatic Diseases / Q000628:therapy*; D001778:Blood Coagulation Disorders / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D019934:International Normalized Ratio; D018570:Risk Assessment; D014859:Warfarin / Q000009:adverse effects*
chemical_list: D000925:Anticoagulants; D014859:Warfarin